HORIZON 2020 Industrial Leadership Call for Nanotechnologies, Advanced Materials and Production Nanomedicine therapy for cancer

Looking for partners

Budget: €152,000,000 H2020-NMP-2015-two-stage
Deadline Date: 26-03-2015
Deadline Date Stage 2: 08-09-2015
Programme: Horizon 2020
MAX Co-funding rate: 100%
Applicants: Research centres, Local and Regional authorities, SME
Regions: European Union, Candidate countries, European Economic Area
Eligibility conditions: Three legal entities. Each of the three shall be established in a different Member State or associated country. All three legal entities shall be independent of each other.

If You like see more detailed information about this call, and others, please subscribe EU Funds Register internet package.

The aim is to translate promising novel nano-technology enabled therapies for cancer with pre-clinical proof-of-concept, from a pre-clinical lab stage up to Phase I clinical testing.